< Back to companies

Turing Biosystems tackles the problems of high failure rates and high toxicity in immunotherapy and cell & gene therapy. Our software platform integrates clinical and biological data to analyse patient responses to therapy and design better treatments. The platform is based on a new kind of interpretable AI, built on modern hardware and using automated reasoning. Our platform is able to integrate all types of multimodal data and information available on a patient or a cohort, such as metadata, health records, multi-omics (epigenomics to metabolomics), tissue and imaging data, public data and prior knowledge to inform the analysis. Our AI is designed to focus on clinical outcomes optimization to improve the safety and efficacy of therapies for patients, clinicians, and biopharma.

Share
Shareable draft
Get Involved in Turing Biosystems

Company Info

Founded
2021
Website
www.turingdb.ai/

Categories

TherapeuticsBiotechClinical Data ManagementPrecision Medicine

Disease Areas

Technologies

Software PlatformData IntegrationComputational BiologyBioinformatics
Only accessible to MedStartr community members. Join now

What do you think of Turing Biosystems?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Turing Biosystems
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free